OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Gastroenterology is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-07-01 to 2025-07-01.)

Article	Citations
Corynoline protects chronic pancreatitis via binding to PSMA2 and alleviating pancreatic fibrosis	267
Clinical features and oncological outcomes of intestinal cancers associated with ulcerative colitis and Crohn’s disease	191
Ratio of submucosal thickness to total bowel wall thickness as a new sonographic parameter to estimate endoscopic remission of ulcerative colitis	154
Artificial intelligence (AI) models for the ultrasonographic diagnosis of liver tumors and comparison of diagnostic accuracies between AI and human experts	107
Correlation between mismatch repair and survival of patients with gastric cancer after 5-FU-based adjuvant chemotherapy	90
Revisiting the relationship between thyroid function and metabolic dysfunction-associated steatotic liver disease in the era of resmetirom	83
Induction of ferroptosis by photodynamic therapy and enhancement of antitumor effect with ferroptosis inducers	71
High-risk population of progressive hepatic fibrosis in chronic hepatitis B patients on antiviral therapy	65
Risk of gastric and oesophageal adenocarcinoma following discontinuation of long-term proton-pump inhibitor therapy	64
Three-dimensional chromatin landscapes in hepatocellular carcinoma associated with hepatitis B virus	49
Alpha-fetoprotein combined with initial tumor shape irregularity in predicting the survival of patients with advanced hepatocellular carcinoma treated with immune-checkpoint inhibitors: a retrospectiv	49
Managing radiation safety and protection in gastroenterology in Japan: insights from the REX-GI study	46
Integrated analysis of tertiary lymphoid structures in relation to tumor-infiltrating lymphocytes and patient survival in pancreatic ductal adenocarcinoma	45
Non-alcoholic fatty liver disease in patients with morbid obesity: the gut microbiota axis as a potential pathophysiology mechanism	45
Novel subharmonic-aided pressure estimation for identifying high-risk esophagogastric varices	43
Predictive factors for the progression of primary localized stage small-bowel follicular lymphoma	41
Reply to: Minocycline versus tetracycline in bismuth-containing quadruple therapy for Helicobacter pylori rescue treatment: a multicentre, randomized controlled trial	40
Considerations for evaluating antibiotic prophylaxis in cirrhotic patients with upper gastrointestinal bleeding in real-world data	39
Clinical factors to predict changes of esophagogastric varices after sustained viral response with direct-acting antiviral therapy	36
Clinicopathological features and prognosis of primary small bowel adenocarcinoma: a large multicenter analysis of the JSCCR database in Japan	31
Associations between excessive supragastric belching and esophageal reflux factors in patients with PPI-refractory GERD in Japan	28
The absence of warfarin treatment and situs inversus are associated with the occurrence of hepatocellular carcinoma after Fontan surgery	28
Successful induction of human chemically induced liver progenitors with small molecules from damaged liver	28
Clinical practice guidelines for duodenal cancer 2021	27
Association between homologous recombination deficiency and time to treatment failure to platinum-based chemotherapy for pancreatic cancer by using the C-CAT database	27

Induction therapy with hepatic arterial infusion chemotherapy enhances the efficacy of lenvatinib and pd1 inhibitors in treating hepatocellular carcinoma patients with portal vein tumor thrombosis	27
Immunity in digestive diseases: new drugs for inflammatory bowel disease treatment—insights from Phase II and III trials	27